Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Feb-24 1:38 PM View:  | Hull Andrew Director | Inmed Pharmaceuticals Inc. (INM) | 21-Feb-24 | Private Purchase | 37,500 | $0.39 | $14,625.00 | 4947% 0.76K to 38.26K | |
| 21-Feb-24 2:58 PM View: | Adams Eric A President & CEO Director | Inmed Pharmaceuticals Inc. (INM) | 20-Feb-24 | Private Purchase | 41,600 | $0.36 | $14,921.90 | 1763% 2.36K to 43.96K | |
| 18-Apr-22 11:46 AM View: | Adams Eric A President & CEO Director | Inmed Pharmaceuticals Inc. (INM) | 14-Apr-22 | Private Purchase | 14,160 | $0.89 | $12,659.00 | 32% 44.84K to 59.0K | |
| 13-Apr-22 9:43 PM View: | Adams Eric A President & CEO Director | Inmed Pharmaceuticals Inc. (INM) | 13-Apr-22 | Private Purchase | 8,560 | $0.85 | $7,276.00 | 24% 36.28K to 44.84K | |
| 24-Jan-22 2:02 PM View: | Colwill Bruce CFO | Inmed Pharmaceuticals Inc. (INM) | 24-Jan-22 | Private Purchase | 5,000 | $1.09 | $5,438.50 | 77% 6.51K to 11.52K | |
| 06-Jan-22 6:40 PM View: | Johnson Shane Aaron SVP, GM of BayMedica LLC | Inmed Pharmaceuticals Inc. (INM) | 06-Jan-22 | Market Purchase | 8,500 | $1.26 | $10,710.00 | 3% 296.1K to 304.6K | 6% |
| 30-Dec-21 7:22 PM View: | Johnson Shane Aaron SVP, GM of BayMedica LLC | Inmed Pharmaceuticals Inc. (INM) | 30-Dec-21 | Market Purchase | 8,093 | $1.33 | $10,736.20 | 3% 288.0K to 296.1K | (< 1%) |
| 15-Nov-21 3:33 PM View: | Johnson Shane Aaron SVP, GM of BayMedica LLC | Inmed Pharmaceuticals Inc. (INM) | 15-Nov-21 | Market Purchase | 5,000 | $1.37 | $6,845.00 | 2% 283.0K to 288.0K | 33% |
| 30-Sep-21 1:39 PM View: | Adams Eric A President & CEO Director | Inmed Pharmaceuticals Inc. (INM) | 29-Sep-21 | Market Purchase | 8,800 | $1.73 | $15,224.00 | 32% 27.48K to 36.28K | 5% |
| 29-Sep-21 1:59 PM View: | Colwill Bruce CFO | Inmed Pharmaceuticals Inc. (INM) | 28-Sep-21 | Market Purchase | 5,000 | $1.77 | $8,840.00 | 330% 1.51K to 6.51K | 3% |
| 29-Sep-21 2:00 PM View: | Adams Eric A President & CEO Director | Inmed Pharmaceuticals Inc. (INM) | 28-Sep-21 | Market Purchase | 11,400 | $1.75 | $19,984.20 | 71% 16.08K to 27.48K | 3% |
